Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Wareham

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Virulence|April 9, 2015
Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella modelHolly Ciesielczuk, Jonathon Betts, Lynnette Phee, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' responseDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei DarussalamMuhd Haziq F Abdul Momin, Apostolos Liakopoulos, David C Bean, et al.
Journal of Clinical Microbiology|November 27, 2015
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in EnterobacteriaceaeDavid W Wareham, Rishita Shah, Jonathan W Betts, et al.
Journal of Materials Chemistry. B|April 9, 2020
Whiter, brighter, and more stable cellulose paper coated with antibacterial carboxymethyl starch stabilized ZnO nanoparticlesFei Cheng, Jonathan W Betts, Stephen M Kelly, et al.
Journal of Medical Microbiology|October 7, 2017
CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogensMuhd Haziq F Abdul Momin, David C Bean, Rene S Hendriksen, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2018
OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coliDavid M Livermore, Michaela Day, Paul Cleary, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producing Escherichia coli in units or networksMichael R Millar, Jo Seale, Jane Turton, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumanniiMarta Martínez-Guitián, Juan C Vázquez-Ucha, Joshua Odingo, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Virulence|April 9, 2015
Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella modelHolly Ciesielczuk, Jonathon Betts, Lynnette Phee, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' responseDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei DarussalamMuhd Haziq F Abdul Momin, Apostolos Liakopoulos, David C Bean, et al.
Journal of Clinical Microbiology|November 27, 2015
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in EnterobacteriaceaeDavid W Wareham, Rishita Shah, Jonathan W Betts, et al.
Journal of Materials Chemistry. B|April 9, 2020
Whiter, brighter, and more stable cellulose paper coated with antibacterial carboxymethyl starch stabilized ZnO nanoparticlesFei Cheng, Jonathan W Betts, Stephen M Kelly, et al.
Journal of Medical Microbiology|October 7, 2017
CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogensMuhd Haziq F Abdul Momin, David C Bean, Rene S Hendriksen, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2018
OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coliDavid M Livermore, Michaela Day, Paul Cleary, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2016
ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producing Escherichia coli in units or networksMichael R Millar, Jo Seale, Jane Turton, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumanniiMarta Martínez-Guitián, Juan C Vázquez-Ucha, Joshua Odingo, et al.
Pageof 7